2022 ACSM共识声明：2型糖尿病患者的运动/体力活动

2022-01-10 美国运动医学会 Med Sci Sports Exerc

2022年，美国运动医学会(ACSM)发布了2型糖尿病患者的运动/体力活动共识声明，本文是对2010年ACSM关于运动和2型糖尿病立场声明的更新，文章简要总结了当前证据，并扩展和更显了之前的建议。

中文标题：

英文标题：

Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine

发布机构：

美国运动医学会

发布日期：

2022-01-10

简要介绍：

2022年，美国运动医学会(ACSM)发布了2型糖尿病患者的运动/体力活动共识声明，本文是对2010年ACSM关于运动和2型糖尿病立场声明的更新，文章简要总结了当前证据，并扩展和更显了之前的建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ea0381c002323a44, title=2022 ACSM共识声明：2型糖尿病患者的运动/体力活动, enTitle=Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine, guiderFrom=Med Sci Sports Exerc, authorId=0, author=, summary=2022年，美国运动医学会(ACSM)发布了2型糖尿病患者的运动/体力活动共识声明，本文是对2010年ACSM关于运动和2型糖尿病立场声明的更新，文章简要总结了当前证据，并扩展和更显了之前的建议。, cover=https://img.medsci.cn/2022117/1642414004186_1608702.png, journalId=0, articlesId=null, associationId=115, associationName=美国运动医学会, associationIntro=American College of Sports Medicine （ACSM）是一家专业运动医学行业协会，它成立于1954年。目前在超过75个国家中拥有20,000多名会员。ACSM旨在致力于通过它在运动科学、体育教育和医学领域先进的科学成果来铺建人类健康之路。“Exercise is medicine!(运动史良药)”是ACSM的核心理念。ACSM的工作任务：促进和融合了运动医学的科学研究，教育和实践，从而保持和提高人体肢体活动的表现，做到健实、健康和生活质量。, copyright=0, guiderPublishedTime=Mon Jan 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年，美国运动医学会(ACSM)发布了2型糖尿病患者的运动/体力活动共识声明，本文是对2010年ACSM关于运动和2型糖尿病立场声明的更新，文章简要总结了当前证据，并扩展和更显了之前的建议。</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=6138, tagName=体力活动), TagDto(tagId=10550, tagName=2型糖尿病患者)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5430, appHits=114, showAppHits=0, pcHits=745, showPcHits=5316, likes=0, shares=13, comments=8, approvalStatus=1, publishedTime=Mon Jan 17 18:02:31 CST 2022, publishedTimeString=2022-01-10, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Jan 17 18:08:00 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 13:35:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ACSM共识声明：2型糖尿病患者的运动_体力活动.pdf)])

2022 ACSM共识声明：2型糖尿病患者的运动_体力活动.pdf

下载请点击：

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2093916, encodeId=7a7f2093916ae, content=为什么下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd8352037, createdName=ms7000001459764669, createdTime=Sat Oct 15 12:45:42 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219063, encodeId=8eaf121906383, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185974, encodeId=52c811859e450, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e462595996, createdName=312488256, createdTime=Wed Jan 19 12:17:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185532, encodeId=d55d1185532b4, content=共识非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Tue Jan 18 10:18:37 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185442, encodeId=1c60118544241, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:53 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-10-15 ms7000001459764669

为什么下不了

39 0
[GetPortalCommentsPageByObjectIdResponse(id=2093916, encodeId=7a7f2093916ae, content=为什么下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd8352037, createdName=ms7000001459764669, createdTime=Sat Oct 15 12:45:42 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219063, encodeId=8eaf121906383, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185974, encodeId=52c811859e450, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e462595996, createdName=312488256, createdTime=Wed Jan 19 12:17:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185532, encodeId=d55d1185532b4, content=共识非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Tue Jan 18 10:18:37 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185442, encodeId=1c60118544241, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:53 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-05-12 湘雅科教

学习学习再学习！

46 0
[GetPortalCommentsPageByObjectIdResponse(id=2093916, encodeId=7a7f2093916ae, content=为什么下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd8352037, createdName=ms7000001459764669, createdTime=Sat Oct 15 12:45:42 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219063, encodeId=8eaf121906383, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185974, encodeId=52c811859e450, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e462595996, createdName=312488256, createdTime=Wed Jan 19 12:17:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185532, encodeId=d55d1185532b4, content=共识非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Tue Jan 18 10:18:37 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185442, encodeId=1c60118544241, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:53 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-01-19 312488256

非常实用

74 0
[GetPortalCommentsPageByObjectIdResponse(id=2093916, encodeId=7a7f2093916ae, content=为什么下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd8352037, createdName=ms7000001459764669, createdTime=Sat Oct 15 12:45:42 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219063, encodeId=8eaf121906383, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185974, encodeId=52c811859e450, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e462595996, createdName=312488256, createdTime=Wed Jan 19 12:17:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185532, encodeId=d55d1185532b4, content=共识非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Tue Jan 18 10:18:37 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185442, encodeId=1c60118544241, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:53 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-01-18 悠游小鱼儿

共识非常使用

82 0
[GetPortalCommentsPageByObjectIdResponse(id=2093916, encodeId=7a7f2093916ae, content=为什么下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adbd8352037, createdName=ms7000001459764669, createdTime=Sat Oct 15 12:45:42 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219063, encodeId=8eaf121906383, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:41:54 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185974, encodeId=52c811859e450, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e462595996, createdName=312488256, createdTime=Wed Jan 19 12:17:38 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185532, encodeId=d55d1185532b4, content=共识非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Tue Jan 18 10:18:37 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185442, encodeId=1c60118544241, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:53 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
2022-01-18 ms6000000807686529

很好

73 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌指南

2022 ACSM共识声明：2型糖尿病患者的运动/体力活动

相关指南

科室

工具

服务